Hepatitis B Vaccine Series Completion by 18 Months in Infants Without a Birth Dose

Key Points

• To assess the completion rates of the hepatitis B vaccination series by 18 months in infants with and without a birth dose.
• Cohort study design comparing two groups of infants: those who received a birth dose of the hepatitis B vaccine and those who did not.
• Outcomes measured include the rate of completion of the hepatitis B vaccination series by 18 months.
• Infants who received a birth dose showed higher completion rates of the hepatitis B vaccine series by 18 months.
• Specific completion rates and statistical analyses were not detailed in the abstract.